This week we are once again providing an update on the most recent drug shortages noting 71 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
OctariusRx President and Consultant Pharmacist Victor Alves is presenting “Survey-Ready Infection Control: Practical Guidance from a Consultant Pharmacist” at the 2026 New England ASC Conference, presented by the Massachusetts Association of Ambulatory Surgery Centers.
This week we are once again providing an update on the most recent drug shortages noting 73 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
The FDA has approved numerous new medications in 2026. Review the latest approvals through June 24, 2026, and discover why staying current is essential for medication reconciliation, survey readiness, and patient safety.
This week we are once again providing an update on the most recent drug shortages noting 76 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
This week we are once again providing an update on the most recent drug shortages noting 75 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Learn how ophthalmology ASCs can safely navigate the trypan blue shortage using pharmacist-led strategies, clinical alternatives, and conservation best practices.
Another year has flown by. Unbelievably, we are quickly approaching 2026 and it’s time to look back at the biggest topics of 2025.
This Thanksgiving, OctariusRx celebrates gratitude for our clients, partners, and healthcare teams. Wishing you a joyful and peaceful holiday!
